+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Involvement of Arachidonic Acid Cascade Pathways in lnterleukin-6-Stimulated Corticotropin-Releasing Factor Release in vitro

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          We have demonstrated that centrally administered interleukin-6 (IL-6) stimulates adrenocorticotropin (ACTH) secretion by a direct effect on corticotropin-releasing factor (CRF) release from the hypothalamus. Since metabolites of the arachidonic acid cascade (AAC) have been implicated in mediating actions of cytokines in different tissues and some AAC inhibitors were able to block pyrogenic effects of cytokines and suppress IL-1-induced ACTH secretion, we decided to examine the mechanism of IL-6 action on CRF release in vitro. After a 60-min preincubation in Krebs-Ringer bicarbonate buffer, medial basal hypothalami (MBH) were preincubated for 30 min with dexamethasone (DEX), a phospholipase A<sub>2</sub> (PLA<sub>2</sub>) inhibitor, to block arachidonic acid (AA) formation, or with inhibitors of AA metabolism: a cyclooxygenase inhibitor – indomethacin (IND); a lipoxygenase inhibitor – 5,8,11-eicosatriynoic acid (EΗ), and an epoxygenase inhibitor – clotrimazole (CLO). Then, the medium was discarded and MBH were incubated with medium or the above compounds and/or IL-6 for 30 min, and CRF release into the incubation medium was measured by radioimmunoassay. As reported previously, 10<sup>–13</sup> M IL-6 increased CRF release, which was significantly suppressed by DEX in a dose-dependent manner. The suppression was already highly significant at a concentration of 10<sup>–11</sup> M DEX and became maximal at 10<sup>–7</sup> M, at which concentration CRF release was no longer stimulated by IL-6. The response to IL-6 was completely blocked at the highest DEX concentration evaluated (10<sup>–5</sup> M). CLO also suppressed IL-6-induced CRF release with a minimal effective dose of 10<sup>–9</sup> M. Suppression was complete at 10<sup>–7</sup> and 10<sup>–5</sup> M. IL-6-stimulated CRF release was suppressed significantly only by higher than micromolar concentrations of IND and EΗ. The results suggest that IL-6 stimulates CRF release by the activation of the AAC system and show that PLA<sub>2</sub> and epoxygenase inhibitors are far more effective than cyclooxygenase and lipoxygenase inhibitors to block IL-6-stimulated CRF release in vitro. The results suggest an important role for the PLA<sub>2</sub> pathway and the epoxygenase pathway in IL-6-induced CRF and ACTH release.

          Related collections

          Author and article information

          S. Karger AG
          07 April 2008
          : 55
          : 6
          : 708-713
          Neuropeptide Division, Department of Physiology, The University of Texas Southwestern Medical Center, Dallas, Tex., USA
          126190 Neuroendocrinology 1992;55:708–713
          © 1992 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Original Paper


          Comment on this article